The impact of charlson comorbidity index on mortality from SARS‐CoV‐2 virus infection and A novel COVID‐19 mortality index: CoLACD Y Varol, B Hakoglu, A Kadri Cirak, G Polat, B Komurcuoglu, B Akkol, ... International journal of clinical practice 75 (4), e13858, 2021 | 52 | 2021 |
Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease G Karadeniz, S Aktoğu, OF Erer, SB Kır, S Doruk, M Demir, K Sonat Biomarkers in Medicine 10 (7), 701-710, 2016 | 39 | 2016 |
C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations G Karadeniz, G Polat, G Senol, M Buyuksirin Inflammation 36 (4), 948-953, 2013 | 36 | 2013 |
İç hastalıkları hemşireliğinde teoriden uygulamaya temel yaklaşımlar G Karadeniz Ankara: Baran Ofset, 2008 | 22 | 2008 |
Effects of a home-based pulmonary rehabilitation program with and without telecoaching on health-related outcomes in COVID-19 survivors: a randomized controlled clinical study H Şahın, İ Naz, G Karadeniz, O Süneçlı, G Polat, O Ediboğlu Jornal Brasileiro de Pneumologia 49 (01), e20220107, 2023 | 20 | 2023 |
The impact of anti-smoking laws on high school students in Ankara, Turkey M Demir, G Karadeniz, F Demir, C Karadeniz, H Kaya, D Yenibertiz, ... Jornal Brasileiro de Pneumologia 41 (6), 523-529, 2015 | 18 | 2015 |
Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR M Gayaf, G Karadeniz, F Güldaval, G Polat, M Türk Expert Review of Respiratory Medicine 15 (6), 845-851, 2021 | 17 | 2021 |
Contribution of cell block obtained by thoracentesis in the diagnosis of malignant pleural effusion F Güldaval, C Anar, G Polat, M Gayaf, MY Yavuz, A Korkmaz, İO Alıcı, ... Journal of cytology 36 (4), 205-208, 2019 | 17 | 2019 |
Can the level of crp in acute pulmonary embolism determine early mortality? M Büyükşirin, C Anar, G Polat, G Karadeniz Turkish Thoracic Journal 22 (1), 4, 2021 | 14 | 2021 |
Insidious Hughes Stovin syndrome: journey from pulmonary embolism to pulmonary arterial aneurysm M Keskin, G Polat, A Ayrancı, G Karadeniz, FD Üçsular, M Büyükşirin, ... Turkish Thoracic Journal 21 (5), 350, 2020 | 13 | 2020 |
Correlation between chest CT severity scores and clinical and biochemical parameters of COVID‐19 pneumonia B Komurcuoglu, S Susam, Ö Batum, MA Turk, B Salik, G Karadeniz, ... The Clinical Respiratory Journal 16 (7), 497-503, 2022 | 12 | 2022 |
Immunization in the chronic obstructive pulmonary disease: can we have really done it OF Erer, G Karadeniz, D Gazibaba, G Ürpek, E Yalnız, SÖ Aktoğu İzmir Göğüs Hastanesi Dergisi 27 (1), 31-40, 2013 | 11 | 2013 |
Predictive value of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hypersensitivity pneumonia F Üçsular, G Polat, G Karadeniz, A Ayranci, M Keskin, M Buyukşirin, ... Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 37 (4), 2020 | 10 | 2020 |
Predictive value of platelet-to-lymphocyte ratio in patients with sarcoidosis E Yalnız, G Karadeniz, FD Üçsular, G Erbay Polat, GV Şahin Biomarkers in Medicine 13 (3), 197-204, 2019 | 10 | 2019 |
KRONİK OBSTRÜKTİF AKCİĞER HASTALIĞINDA AŞILANMA; GERÇEKTEN YAPTIRTIYOR MUYUZ? OF ERER, G KARADENİZ, D GAZİBABA, G ÜRPEK, E YALNIZ, ... İzmir Göğüs Hastanesi Dergisi 27 (1), 31-40, 2013 | 10 | 2013 |
A rare complication of acupuncture: pneumothorax M Demir, M Oruç, A Dallı, H Kaya, G Karadeniz Tuberkuloz ve toraks 62 (4), 316-318, 2014 | 9 | 2014 |
Evaluation of the relationships between procalcitonin and neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with pneumonia E Çil, G Karadeniz, S Yenigün, G Çoraplı Eur. Rev. Med. Pharmacol 26, 3200-3205, 2022 | 6 | 2022 |
Are idiopathic pulmonary fibrosis patients more anxious and depressive than patient’s with other interstitial lung disease? E Yalnız, G Polat, F Demirci, S Deniz, G Karadeniz, E Aydınlı, G Vayisoglu, ... Sarcoidosis, Vasculitis, and Diffuse Lung Diseases 36 (4), 294, 2019 | 6 | 2019 |
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis F Ucsular, G Karadeniz, C Karadeniz, E Yalnız, M Demir Sarcoidosis Vasc Diffuse Lung Dis 33 (2), 151-6, 2016 | 6 | 2016 |
What are the differences between smoker and non-smoker COPD cases? Is it a different phenotype? F Güldaval, G Polat, S Doruk, G Karadeniz, A Ayranci, M Türk, M Gayaf, ... Turkish Thoracic Journal 22 (4), 284, 2021 | 5 | 2021 |